Skip to main content
Category

News Archive

nea-logo

New Enterprise Associates ranks among top VC firms for best exits according to CB Insights report along with Sequoia Capital and Accel Partners – Washington Business Journal

By News Archive

nea-logo

Chevy Chase-based New Enterprise Associates ranked among the VC firms with the best exits (meaning biggest acquisitions and initial public offerings) between 2009 and 2015, according to a new report from CB Insights.

Silicon Valley firms Sequoia Capital and Accel Partners were also included at the top of the list.

Read More
genarraytion-logo

Press Release — GenArraytion Inc

By News Archive

genarraytion-logo

GenArraytion, Inc., is pleased to announce a manufacturing license agreement with Chemring Detection Systems, Inc. (“CDS”), a subsidiary of Chemring Sensors & Electronic Systems (CSES) and part of Chemring Group PLC (“Chemring”), in support of the development of the Commercial-Off-the-Shelf (COTS) Athina Consumable Cartridge product. GenArraytion will provide a highly multiplexed molecular assay panel on Luminex magnetic beads that will detect multiple biological warfare agents in a single reaction as part of the Athina Consumable Cartridge solution. 

CDS was awarded a $14,934,533 cost-plus-incentive-fee incrementally funded JBTDS contract with options last month.  The Athina product technology is the basis for the awarded JBTDS solution. Fiscal year 2015 research, development, testing and evaluation funds in the amount of $4,456,639 were obligated at the time of the award.  CSES was granted the contract after an evaluation and selection process that began in early 2014.

Read More
exit-sign-pixa

Sequoia Capital, Accel Partners, New Enterprise Associates rated tops for big exits – Silicon Valley Business Journal

By News Archive

exit-sign-pixa

Three venture firms stand out in a new study by CB Insight of who consistently enjoyed the biggest exits — IPOs or sales — of their portfolio companies.

Sequoia Capital, Accel Partners and New Enterprise Associates had at least five of the top exits in two windows used in the study. They were the only ones to be in the top five for both periods used in the CB Insights research.

Read More
computer-tech-pixa

US Government Funds $3 Million Cryptocurrency Research Initiative

By News Archive

computer-tech-pixa

Three American universities are set to conduct wide-ranging research on cryptocurrencies using roughly $3m in grant funding from the National Science Foundation, a US government agency that supports and funds scientific research.

Cornell, the University of Maryland and the University of California Berkeley will focus on developing new cryptocurrency systems that, according to principal investigator Elaine Shi, will address “pain points” attributed to bitcoin and other existing networks.

Read More
leidos-logo

UPDATED: Leidos Wins Massive Pentagon Health Care Records Contract – Nextgov.com

By News Archive

Tleidos-logohe Pentagon today awarded its years-in-the-making multibillion contract to upgrade its electronic health records system, to defense IT firm Leidos, which partnered with electronic health record vendor Cerner and Accenture Federal.

The Defense Healthcare Management Systems Modernization contract’s base value is $4.3 billion over 10 years, with an expected 18-year lifecycle value of $9 billion, and will put Leidos in charge of building a next-generation health records system responsible for DOD’s 9.6 million beneficiaries.

Read More
deerfield-management-logo

With $550M Fund, Deerfield Management Tackles Early Stage Biotech – Xconomy

By News Archive

deerfield-management-logo

Developing lab research into the foundations of a profitable biotech company has always been a high-risk, high-reward business.

Deerfield Management, a New York-based healthcare investor with more than $5 billion under management and two decades of experience, has created a new $550 million fund that targets early stage science from academic medical centers and hospitals. The fund is specifically focused on innovative treatments for genetic disorders, cancer, and orphan diseases.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.